Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2013-10-23
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DELUSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-26 (study day 155.0); relationship: REMOTE
severe
assessed
2026-08-18
Severe HIP FRACTURE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-25 (study day 64.0); relationship: NONE; serious criteria: hospitalization
severe
assessed
2026-08-18
Severe HIP FRACTURE — outcome: RECOVERED/RESOLVED; onset 2013-12-25 (study day 64.0); relationship: NONE; serious criteria: hospitalization
mild
assessed
2026-08-18
Mild PSYCHOMOTOR HYPERACTIVITY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-26 (study day 155.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.